Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Yates

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
RMD Open|August 17, 2021
Exploring the macro-level, meso-level and micro-level barriers and facilitators to the provision of good quality early inflammatory arthritis (EIA) care in England and WalesMagdalena Zasada, Mark Yates, Nicola Ayers, et al.
The European Respiratory Journal|October 3, 2020
COVID-19: opacification score is higher in the right lung and right lung involvement is a better predictor of ICU admissionDeepak Nagra, Mark Russell, Mark Yates, et al.
International Journal of Environmental Research and Public Health|February 6, 2019
Evaluating the Impact of the Dementia Care in Hospitals Program (DCHP) on Hospital-Acquired Complications: Study ProtocolMark Yates, Jennifer J Watts, Kasia Bail, et al.
Frontiers in Psychiatry|December 20, 2024
Using cerebrospinal fluid biomarkers to diagnose Alzheimer's disease: an Australian perspectiveDhamidhu Eratne, Steven Collins, Peter J Nestor, et al.
BMC Health Services Research|September 20, 2019
Impact of the Dementia Care in Hospitals Program on acute hospital staff satisfactionMargaret E Murray, Anna Wong Shee, Emma West, et al.
Rheumatology (Oxford, England)|October 7, 2020
Corrigendum to: Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British Society for Rheumatology Biologics RegisterKatie Bechman, Anuoluwapo Oke, Mark Yates, et al.
Rheumatology (Oxford, England)|January 31, 2020
Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British Society for Rheumatology Biologics RegisterKatie Bechman, Anuoluwapo Oke, Mark Yates, et al.
The Journal of Rheumatology|September 17, 2019
Rising Incidence of Acute Hospital Admissions due to GoutMark D Russell, Mark Yates, Katie Bechman, et al.
The Journal of Rheumatology|May 16, 2021
Systematic Review and Metaanalysis of the Reproducibility of Patient Self-reported Joint Counts in Rheumatoid ArthritisSanketh Rampes, Vishit Patel, Ailsa Bosworth, et al.
Arthritis Research & Therapy|April 19, 2020
Data quality predicts care quality: findings from a national clinical auditMark Yates, Katie Bechman, Elaine M Dennison, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
RMD Open|August 17, 2021
Exploring the macro-level, meso-level and micro-level barriers and facilitators to the provision of good quality early inflammatory arthritis (EIA) care in England and WalesMagdalena Zasada, Mark Yates, Nicola Ayers, et al.
The European Respiratory Journal|October 3, 2020
COVID-19: opacification score is higher in the right lung and right lung involvement is a better predictor of ICU admissionDeepak Nagra, Mark Russell, Mark Yates, et al.
International Journal of Environmental Research and Public Health|February 6, 2019
Evaluating the Impact of the Dementia Care in Hospitals Program (DCHP) on Hospital-Acquired Complications: Study ProtocolMark Yates, Jennifer J Watts, Kasia Bail, et al.
Frontiers in Psychiatry|December 20, 2024
Using cerebrospinal fluid biomarkers to diagnose Alzheimer's disease: an Australian perspectiveDhamidhu Eratne, Steven Collins, Peter J Nestor, et al.
BMC Health Services Research|September 20, 2019
Impact of the Dementia Care in Hospitals Program on acute hospital staff satisfactionMargaret E Murray, Anna Wong Shee, Emma West, et al.
Rheumatology (Oxford, England)|October 7, 2020
Corrigendum to: Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British Society for Rheumatology Biologics RegisterKatie Bechman, Anuoluwapo Oke, Mark Yates, et al.
Rheumatology (Oxford, England)|January 31, 2020
Is background methotrexate advantageous in extending TNF inhibitor drug survival in elderly patients with rheumatoid arthritis? An analysis of the British Society for Rheumatology Biologics RegisterKatie Bechman, Anuoluwapo Oke, Mark Yates, et al.
The Journal of Rheumatology|September 17, 2019
Rising Incidence of Acute Hospital Admissions due to GoutMark D Russell, Mark Yates, Katie Bechman, et al.
The Journal of Rheumatology|May 16, 2021
Systematic Review and Metaanalysis of the Reproducibility of Patient Self-reported Joint Counts in Rheumatoid ArthritisSanketh Rampes, Vishit Patel, Ailsa Bosworth, et al.
Arthritis Research & Therapy|April 19, 2020
Data quality predicts care quality: findings from a national clinical auditMark Yates, Katie Bechman, Elaine M Dennison, et al.
Pageof 9